LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 49.63 | 27.76 | 413 | 4818 | 0.0857 | 0.4375 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 49.63 | 27.76 | 6055 | 4818 | 1.2567 | 1.0624 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 49.63 | 27.76 | 911 | 4818 | 0.1891 | 0.5988 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 49.63 | 27.76 | 6302 | 4818 | 1.3080 | 1.0735 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 51.33 | 27.76 | 513 | 5117 | 0.1003 | 0.4734 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 51.33 | 27.76 | 6484 | 5117 | 1.2671 | 1.0639 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 51.33 | 27.76 | 935 | 5117 | 0.1827 | 0.5957 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 51.33 | 27.76 | 6607 | 5117 | 1.2912 | 1.0691 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.04 | 27.76 | 498 | 5365 | 0.0928 | 0.4625 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.04 | 27.76 | 6805 | 5365 | 1.2682 | 1.0636 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.04 | 27.76 | 1091 | 5365 | 0.2033 | 0.6216 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.04 | 27.76 | 6895 | 5365 | 1.2850 | 1.0671 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.74 | 27.76 | 458 | 5606 | 0.0817 | 0.4421 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.74 | 27.76 | 7115 | 5606 | 1.2690 | 1.0632 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.74 | 27.76 | 1080 | 5606 | 0.1926 | 0.6130 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.74 | 27.76 | 7210 | 5606 | 1.2860 | 1.0668 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.45 | 27.76 | 442 | 5745 | 0.0769 | 0.4330 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.45 | 27.76 | 7499 | 5745 | 1.3052 | 1.0705 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.45 | 27.76 | 1101 | 5745 | 0.1916 | 0.6135 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.45 | 27.76 | 7592 | 5745 | 1.3214 | 1.0738 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.15 | 27.76 | 483 | 5906 | 0.0818 | 0.4468 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.15 | 27.76 | 7902 | 5906 | 1.3378 | 1.0767 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.15 | 27.76 | 1036 | 5906 | 0.1754 | 0.5969 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.15 | 27.76 | 7844 | 5906 | 1.3280 | 1.0747 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 59.85 | 27.76 | 487 | 6062 | 0.0803 | 0.4458 | MN20160318_Q01 | J13 |